Unlike some of my Comments of the Day, I’m not posting this one to
mock the reader. A lot of people responded to my Jose Bautista piece
the way the reader below did, and he’s clearly not alone in thinking I have my head up my
butt on the issue of steroids in baseball.
More generally speaking, it’s my hope that, going forward, I can better use the Comment of the Day
feature to bring up these kinds of reader dissents. Less so that I can
rebut them — I get tons of time to do that in other posts — but more so that alternative reader opinions, even ones I
disagree with on about 18 levels, can be given
voice. Like a lot of blogs, this one is not immune to groupthink, and
I’d like to try and combat that. Posting alternative viewpoints without my own commentary is one small way to do that.
With that out of the way, here’s reader mkhill12, responding to my little Jose Bautista rant from yesterday:
Hey, Calcaterra . . . get your head out of your a–. Quit hiding behind
“if you have no proof, please spare us your insinuations to the
contrary.” He went from a career best 16 HRs in one season to FIFTY
FREAKING TWO and there’s still a week left in the season. Let me
repeat: FIFTY FREAKING TWO. He absolutely does NOT deserve the benefit of the doubt, and he can thank Bonds, McGwire, A-Rod, Manny, Brady Anderson, Raffy, Ortiz, Giambi, Clemens, Pettitte and so and and so forth.
Is it fair? No. But life’s not fair.
And you’re serving up of the 2 PED tests that he’s supposedly taken and passed as proof that he’s clean is absolutely comical. Newsflash,
jerky! The current PED test does NOT test for HGH!
Given the revelation of rampant steroid and PED use in MLB in the past
several years, it would be irresponsible if the media did NOT bring up
PEDs when discussing Bautista’s ridiculous year. But you continue to keep your head in the sand….and you probably still believe in Santa Claus and think the Moon is a giant ball of cheese. So do us a favor -get off the soap box and join reality.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.
Jon Morosi of FOX Sports reports that free agent reliever Joe Nathan, recovering from Tommy John surgery, plans to pitch in 2016 according to his agent Dave Pepe. According to Pepe, Nathan’s workouts are “going well” and the right-hander is “definitely planning on playing this year.”
Nathan, 41, got the final out on Opening Day (April 6) against the Twins before going on the disabled list with a flexor strain in his right elbow, causing him to miss the next 161 games. He will likely be able to contribute out of the bullpen in late May or early June if he has no setbacks. On a minor league deal or incentive-laden major league deal, Nathan could make for a low-risk gamble.
Over a 15-season career that dates back to 1999 (he did not pitch in the majors in 2001 or 2010), Nathan has 377 saves with a 2.89 ERA and a 967/340 K/BB ratio over 917 innings.
On Thursday, we learned that the Diamondbacks were still considering free agent reliever Tyler Clippard. You can add the Rays to the list as well, per Marc Topkin of the Tampa Bay Times.
The Rays traded lefty reliever Jake McGee to the Rockies in exchange for outfielder Corey Dickerson in late January, so Clippard would be able to slot right in behind closer Brad Boxberger. Clippard, 30, compiled a 2.92 ERA with 64 strikeouts and 31 walks over 71 innings in a season split between the Athletics and Mets. The strikeout rate was at its lowest since the right-hander become a full-time reliever in 2009, and his walk rate was at its highest since 2010, which may be a factor in his still being a free agent in February.